Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer. Clements became the Palo Alto, California-based diabetes management company’s fractional chief medical officer in 2016. He now steps into an expanded, full-time role designed to integrate Glooko’s clinical vision, product roadmap and data solutions. […]
glooko
Glooko integrates diabetes management platform with Abbott FreeStyle Libre
Glooko announced today that its platform now supports the Abbott FreeStyle Libre continuous glucose monitoring (CGM) in the U.S. The integration further strengthens Glooko’s commitment to offering a comprehensive, all-in-one solution for managing diabetes. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin […]
Glooko, Innovation Zed partner on digital companion apps for injection therapy management
Glooko and Innovation Zed today announced a strategic partnership to develop and deploy digital companion apps for injectable therapies. Palo Alto, California-based Glooko’s current platforms enable patients to share diabetes data with healthcare providers. That includes blood glucose readings, insulin doses, food and carbs, exercise activity, blood pressure and weight. Ireland-based Innovation Zed develops insulin […]
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support. The solution combines connected care, remote patient monitoring and digital therapeutic technologies. It aims to enhance access for people with type 1 and type 2 diabetes requiring advanced bolus insulin dosing support. The companies kicked off their launch in […]
Glooko announces CEO transition with $100M financing
Glooko announced today that it secured $100 million in a financing round and appointed Mike Alvarez as its new CEO. Russ Johannesson said on LinkedIn that he stepped down from the CEO post at Glooko. He held the corner office for six-and-a-half years as Alvarez now takes over. Alvarez brings more than two decades of […]
Glooko adds two new presidents to its leadership team
Glooko announced today that it appointed Dr. David Pass as president of life sciences and Adam Hameed as president of connected care. Palo Alto, California-based Glooko established the new roles to position itself for continued growth and innovation in chronic condition management. It wants to drive advances in life sciences, specifically digital companions/therapeutics, clinical research, […]
Better Therapeutics, Glooko partner on digital diabetes management
Better Therapeutics and Glooko today announced a partnership to integrate technologies and enhance diabetes management. The partnership aims to integrate Better Therapeutics’ ApsyreRx digital behavioral treatment into Glooko’s diabetes management platform. Better Therapeutics designed AspyreRx to treat type 2 diabetes. The FDA authorized AspyreRx as a prescription digital therapeutic for diabetes in July. Palo Alto, […]
Glooko inks partnership with insulin dosing software developer Hedia
Glooko announced that it entered into a global partnership with Hedia to integrate its technology into Glooko’s diabetes management platforms. The companies aim to provide an interoperable solution that brings together connected care, remote patient monitoring and digital therapeutics. This combination could enhance access for those with type 1 and type 2 diabetes requiring bolus […]
Glooko, Sanofi partner on insulin pen connectivity
Glooko announced today that it entered into a partnership with Sanofi to integrate a connected device for insulin pens into its digital platform. SoloSmart, a single-piece, add-on connected device works with Sanofi’s SoloStar and DoubleStar insulin injection pens. It records the insulin dose, date and time of injection. Through this partnership, the company’s can offer […]
Glooko picks up security certification for diabetes patient management platform
Glooko announced today that it received ISO 27001 certification for its data management and remote patient monitoring platforms. Palo Alto, California-based Glooko develops remote patient monitoring and chronic care management products. These include data management technologies for insulin delivery devices. ISO 27001, an international compliance framework, serves as the international security standard for protecting customer […]
